Chronic rhinosinusitis and psoriasis: Do mutually exclusive systemic Th1 and Th2 disease patterns exist?

Acta Oto-Laryngologica

Volumn 127, Issue 7, 2007, Pages 780-783

  Rashid, Rashid M ^a,c   Miller, Andrew ^b   Scianna, Joseph M ^a   Stankiewicz, James A ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c Office of the Dean John Lee   (United States)

Author keywords

Chronic rhinosinusitis; Crohn's disease; Multiple sclerosis; Psoriasis; Rheumatoid arthritis; Th1; Th2

Indexed keywords

ARTICLE; CELLULAR IMMUNITY; CHRONIC DISEASE; CROHN DISEASE; ELECTRONIC MEDICAL RECORD; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PSORIASIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RHINOSINUSITIS; TH1 CELL; TH2 CELL;

ARTHRITIS, RHEUMATOID; CHRONIC DISEASE; CROHN DISEASE; HUMANS; MULTIPLE SCLEROSIS; PSORIASIS; RETROSPECTIVE STUDIES; RHINITIS; SINUSITIS; TH1 CELLS; TH2 CELLS;

EID: 34250623607     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480601002054     Document Type: Article

References (27)

1. Bhattacharyya N. The economic burden and symptom manifestations of chronic rhinosinusitis. Am J Rhinol 2003;17:27-32.
2. Elliott KA, Stringer SP. Evidence-based recommendations for antimicrobial nasal washes in chronic rhinosinusitis. Am J Rhinol 2006;20:1-6.
3. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-93.
4. Herring AC, Hernandez Y, Huffnagle GB, Toews GB. Role and development of TH1/TH2 immune responses in the lungs. Semin Respir Crit Care Med 2004;25:3-10.
5. Shimizu K, Libby P, Mitchell RN. Local cytokine environments drive aneurysm formation in allografted aortas. Trends Cardiovasc Med 2005;15:142-8.
6. Rashid RM, Achille NJ, Lee JM, Lathers DM, Young MR. Decreased T-cell proliferation and skewed immune responses in LLC-bearing mice. J Environ Pathol Toxicol Oncol 2005; 24:175-92.
7. Lathers DM, Young MR. Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck. Cytokine 2004;25:220-8.
8. Weiss R, Scheiblhofer S, Gabler M, Ferreira F, Leitner WW, Thalhamer J. Is genetic vaccination against allergy possible? Int Arch Allergy Immunol 2006;139:332-45.
9. Elhini A, Abdelwahab S, Ikeda K. Th1 and Th2 cell population in chronic ethmoidal rhinosinusitis: a chemokine receptor assay. Laryngoscope 2005;115:1272-7.
10. Kamil A, Ghaffar O, Lavigne F, Taha R, Renzi PM, Hamid Q. Comparison of inflammatory cell profile and Th2 cytokine expression in the ethmoid sinuses, maxillary sinuses, and turbinates of atopic subjects with chronic sinusitis. Otolaryngol Head Neck Surg 1998;118:804-9.
11. Bernstein JM, Ballow M, Rich G, Allen C, Swanson M, Dmochowski J. Lymphocyte subpopulations and cytokines in nasal polyps: is there a local immune system in the nasal polyp? Otolaryngol Head Neck Surg 2004;130:526-35.
12. Lal D, Baroody FM, Weitzel EK, deTineo M, Naclerio RM. Total IgE levels do not change 1 year after endoscopic sinus surgery in patients with chronic rhinosinusitis. Int Arch Allergy Immunol 2006;139:146-8.
13. Riccio AM, Tosca MA, Cosentino C, Pallestrini E, Ameli F, Canonica GW, et al. Cytokine pattern in allergic and nonallergic chronic rhinosinusitis in asthmatic children. Clin Exp Allergy 2002;32:422-6.
14. Tosca MA, Cosentino C, Pallestrini E, Caligo G, Milanese M, Ciprandi G. Improvement of clinical and immunopathologic parameters in asthmatic children treated for concomitant chronic rhinosinusitis. Ann Allergy Asthma Immunol 2003;91:71-8.
15. Bryson JM, Tasca RA, Rowe-Jones JM. Local and systemic eosinophilia in patients undergoing endoscopic sinus surgery for chronic rhinosinusitis with and without polyposis. Clin Otolaryngol Allied Sci 2003;28:55-8.
16. Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol 2003;4:441-7.
17. Matei I, Matei L. Cytokine patterns and pathogenicity in autoimmune diseases. Rom J Intern Med 2002;40:27-41.
18. Ghoreschi K, Rocken M. Immune deviation strategies in the therapy of psoriasis. Curr Drug Targets Inflamm Allergy 2004;3:193-8.
19. Book DT, Smith TL, McNamar JP, Saeian K, Binion DG, Toohill RJ. Chronic sinonasal disease in patients with inflammatory bowel disease. Am J Rhinol 2003;17:87-90.
20. Bartholo RM, Zaltman C, Elia C, Cardoso AP, Flores V, Lago P, et al. Bronchial hyperresponsiveness and analysis of induced sputum cells in Crohn's disease. Braz J Med Biol Res 2005;38:197-203.
21. Keating GM, Perry CM. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis. BioDrugs 2002;16:111-48.
22. Hayakawa H, Sato A, Imokawa S, Toyoshima M, Chida K, Iwata M, et al. Bronchiolar disease in rheumatoid arthritis. Am J Respir Crit Care Med 1996;154:1531-6.
23. Alobid I, Guilemany JM, Mullol J. Nasal manifestations of systemic illnesses. Curr Allergy Asthma Rep 2004;4:208-16.
24. Jones RL, Crowe P, Chavda SV, Pahor AL. The incidence of sinusitis in patients with multiple sclerosis. Rhinology 1997; 35:118-9.
25. Gay D, Dick G, Upton G. Multiple sclerosis associated with sinusitis: case-controlled study in general practice. Lancet 1986;1:815-9.
26. Wang X, Kim J, McWilliams R, Cutting GR. Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation. Arch Otolaryngol Head Neck Surg 2005; 131:237-40.
27. Genovese MC. Biologic therapies in clinical development for the treatment of rheumatoid arthritis. J Clin Rheumatol 2005;11(3 Suppl):S45-S54.